MAPKAPK2 and neoplasm: The pathological structure of tumor tissue improved, and Ki67, FOXM1, p-p38, and p-MK2 levels decreased, further proving that miR-509-3p inhibits GC progression by regulating FOXM1-mediated p38/MK2 pathway activation.